open access

Vol 6, No 1 (2001)
Untitled
Published online: 2001-01-01
Submitted:
Get Citation

89. Results of the breast conserving therapy in early breast cancer

E. Adamiak, D. Fundowicz, M. Matecka-Nowak, P. Milecki, G. Stryczyńska
DOI: 10.1016/S1507-1367(01)70459-2
·
Rep Pract Oncol Radiother 2001;6(1):68.

open access

Vol 6, No 1 (2001)
Untitled
Published online: 2001-01-01
Submitted:

Abstract

Aim

Evaluation outcome of treatment (surgery and radiotherapy) in early breast cancer.

Material and methods

We performed this analysis on sixty eight women with clinical and pathological diagnosis of the early breast cancer (tumour up to 3 cm and without metastases to the axillary lymph nodes) who were treated in our centre between 1993 and 1995. For all patients in the first phase of treatment the breast conserving surgery (quadrantectomy and axillary dissection) was performed. All patients received radiotherapy (Co60 or photons 6 MeV) to total dose 50,4 Gy, daily fractionation 1,8 Gy prescribed to ICRU point. The electron boost to the tumour bed in some cases was applied. The acute and late morbidity were good, without any grade III (RTOG scale). The follow-up was in range 5 – years.

Results

5 (7%) patients of 68 patients had local recurrence and in these cases total mastectomy was performed. 7 (10%) of 68 patients had distant metastases without locoregional recurrence and chemotherapyin these cases were introduced chemotherapy. Patients with the local recurrence only still alive, but 7 patients with distant metastases died.

Conclusions

Crucial for the outcome of treatment early breast cancer is presence of micrometastases before or during local treatment. The results of combined local treatment were good and in case of local relapse the additional surgery give a chance for cure.

Abstract

Aim

Evaluation outcome of treatment (surgery and radiotherapy) in early breast cancer.

Material and methods

We performed this analysis on sixty eight women with clinical and pathological diagnosis of the early breast cancer (tumour up to 3 cm and without metastases to the axillary lymph nodes) who were treated in our centre between 1993 and 1995. For all patients in the first phase of treatment the breast conserving surgery (quadrantectomy and axillary dissection) was performed. All patients received radiotherapy (Co60 or photons 6 MeV) to total dose 50,4 Gy, daily fractionation 1,8 Gy prescribed to ICRU point. The electron boost to the tumour bed in some cases was applied. The acute and late morbidity were good, without any grade III (RTOG scale). The follow-up was in range 5 – years.

Results

5 (7%) patients of 68 patients had local recurrence and in these cases total mastectomy was performed. 7 (10%) of 68 patients had distant metastases without locoregional recurrence and chemotherapyin these cases were introduced chemotherapy. Patients with the local recurrence only still alive, but 7 patients with distant metastases died.

Conclusions

Crucial for the outcome of treatment early breast cancer is presence of micrometastases before or during local treatment. The results of combined local treatment were good and in case of local relapse the additional surgery give a chance for cure.

Get Citation
About this article
Title

89. Results of the breast conserving therapy in early breast cancer

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 6, No 1 (2001)

Pages

68

Published online

2001-01-01

DOI

10.1016/S1507-1367(01)70459-2

Bibliographic record

Rep Pract Oncol Radiother 2001;6(1):68.

Authors

E. Adamiak
D. Fundowicz
M. Matecka-Nowak
P. Milecki
G. Stryczyńska

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl